肿瘤基础与临床
腫瘤基礎與臨床
종류기출여림상
Journal of Basic and Clinical Oncology
2015年
5期
419-420,421
,共3页
老年患者%晚期非小细胞肺癌%复方苦参注射液%吉西他滨%顺铂
老年患者%晚期非小細胞肺癌%複方苦參註射液%吉西他濱%順鉑
노년환자%만기비소세포폐암%복방고삼주사액%길서타빈%순박
elderly patients%advanced non-small cell lung cancer%fufang kushen injection%gemcitabine%cispl-atin
目的:探讨复方苦参注射液联合GP方案治疗老年晚期非小细胞肺癌的近期疗效和毒副反应。方法90例老年晚期非小细胞肺癌患者随机均分为2组(观察组和对照组),每组45例,均接受GP方案治疗,观察组同时给予复方苦参注射液治疗。治疗期间比较观察2组的近期疗效和毒副反应。结果观察组有效率和疾病控制率分别为46.67%(21/45)和77.78%(35/45),对照组分别为42.22%(19/45)和66.67%(30/45),观察组略高,但差异无统计学意义( P跃0.05)。观察组白细胞减少、血红蛋白减少、血小板减少、恶心呕吐、乏力发生率均低于对照组,差异有统计学意义( P<0.05)。结论复方苦参注射液与GP方案联合用于老年晚期非小细胞肺癌的治疗,疗效较好,安全性明显提高。
目的:探討複方苦參註射液聯閤GP方案治療老年晚期非小細胞肺癌的近期療效和毒副反應。方法90例老年晚期非小細胞肺癌患者隨機均分為2組(觀察組和對照組),每組45例,均接受GP方案治療,觀察組同時給予複方苦參註射液治療。治療期間比較觀察2組的近期療效和毒副反應。結果觀察組有效率和疾病控製率分彆為46.67%(21/45)和77.78%(35/45),對照組分彆為42.22%(19/45)和66.67%(30/45),觀察組略高,但差異無統計學意義( P躍0.05)。觀察組白細胞減少、血紅蛋白減少、血小闆減少、噁心嘔吐、乏力髮生率均低于對照組,差異有統計學意義( P<0.05)。結論複方苦參註射液與GP方案聯閤用于老年晚期非小細胞肺癌的治療,療效較好,安全性明顯提高。
목적:탐토복방고삼주사액연합GP방안치료노년만기비소세포폐암적근기료효화독부반응。방법90례노년만기비소세포폐암환자수궤균분위2조(관찰조화대조조),매조45례,균접수GP방안치료,관찰조동시급여복방고삼주사액치료。치료기간비교관찰2조적근기료효화독부반응。결과관찰조유효솔화질병공제솔분별위46.67%(21/45)화77.78%(35/45),대조조분별위42.22%(19/45)화66.67%(30/45),관찰조략고,단차이무통계학의의( P약0.05)。관찰조백세포감소、혈홍단백감소、혈소판감소、악심구토、핍력발생솔균저우대조조,차이유통계학의의( P<0.05)。결론복방고삼주사액여GP방안연합용우노년만기비소세포폐암적치료,료효교호,안전성명현제고。
Objective To investigate the short-term efficacy and toxicities of fufang kushen injection combined with GP regimen in the treatment of elderly patients with advanced non-small-cell lung cancer. Methods All the 90 elderly patients with advanced non-small-cell lung cancer were divided in two groups(45 patients of the observation group and 45 patients of the control group),and received the GP regimen chemotherapy,45 patients of the observa-tion group received fufang kushen injection at the same time. The short-term efficacy and toxicities were compared between the two groups. Results The response rate and the disease control rate of the observation group were 46. 67%(21/45)and 77. 78%(35/45),and were 42. 22%(19/45)and 66. 67%(30/45)of the control group (P>0. 05). The incidences of leucopenia,anemia,thrombocytopenia,nausea and vomiting anergy of the observation group were higher than those of the control group(P<0. 05). Conclusion Fufang kushen injection combined with GP regimen is effective and safe in the treatment of elderly patients with advanced non-small-cell lung cancer.